Qin Ye, MD, MS

Principal, ZS Associates

Based in Washington DC, Dr. Qin Ye is the Global RWE lead for ZS. Qin joined ZS in 2016, where he has been focusing on helping clients realize the value of their RWD investment through our strategy, data science, and technology capabilities. In his role, Qin leads the development of our RWE team, oversees the development of our RWE technology, and works directly with clients on evidence generation and advanced data sciences programs across clinical, HEOR, medical, and market access functions.

As a trained physician, outcome researcher, and data scientist, Qin has over 20 years of health informatics and data analytics experience with in-depth knowledge of medical terminologies, data standards, prospective RWE registries, and various EHR products, pragmatics trials designs, observational study methods, and health economics.

Qin has a distinctive combination of health informatics, life science data analytics, and leadership experiences across the healthcare industry. These include Director, Health Informatics at AstraZeneca where he leads the development of global and cross-functional RWE technology and analytics capabilities; Chief Medical Informatics Officer at Acupera; Executive VP at Medversant Technologies; Associate Medical Director at Pfizer; and Principle Architect at IDX Systems Corp.

Qin holds a medical degree from the School of Medicine, Beijing University, and a Master’s degree in Health Informatics & Outcomes Research from Oregon Health & Science University.

Speaker Sessions

28. Providers and Pharma: Building Bridges to Improve Quality of Care

Level: Advanced
Track: Life Sciences

Providers and pharma have traditionally looked at each other as transactional partners, but that is all changing. There is a new spectrum of opportunities available with what providers already do every day to enhance the quality of care, improve operational outcomes, and drive innovation. Hospital systems are currently the most stressed healthcare pillar—providers are feeling the effects of COVID-19 across outcomes, patient experience, finances, and the well-being of the care team. Many challenges are shared between providers and pharma. The pandemic has solidified the need for a strategic long-term partnership to solve these common challenges by building bridges between providers and pharma through data, technology, and shared expertise.

Join this session to discover:

  • The need for provider and pharma partnerships.
  • Where pharma comes in to play for providers.
  • A collaborative framework.
  • Examples of successful partnerships.

Watch HAS 21 Virtual On-Demand.

Replay HAS 21 Virtual

Unsupported Browser

Unfortunately your web browser is out of date. For improved security, speed and the best experience please consider using the latest version of on the following browsers: Google Chrome, Firefox, Edge, Safari, or Opera.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.